Benzinga
Benzinga
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Benzinga
mercredi, octobre 21
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Assembly Biosciences Inc
ASMB
NASDAQ
Liste de surveillance
Get Report
Trade with Public
Get Report
Trade with Public
$21.19
1.03
5.11%
Dern. MÀJ: Oct 20, 5:00 PM
$21.19
1.03
5.11%
Get Report
Aperçu
Actualités
Prévisions de résultats
Événements
Objectifs de cours
Données financières
Sentiment
Actionnariat
Comparer
Options
Rapport sur les stocks
Privacy Manager
Assembly Biosciences Financials
Assembly Biosciences (ASMB) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Assembly Biosciences Q2 EPS $(0.20) Beats $(0.65) Estimate, Sales $13.374M Beat $8.599M Estimate
Assembly Biosciences (NASDAQ:ASMB) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.65) by 69.23 percent. This is a 84.96 percent increase over losses of $(1.33) per share
Benzinga Newsdesk
PRO
Assembly Biosciences Q1 EPS $(0.54) Beats $(0.71) Estimate, Sales $8.213M Miss $9.266M Estimate
Assembly Biosciences (NASDAQ:ASMB) reported quarterly losses of $(0.54) per share which beat the analyst consensus estimate of $(0.71) by 23.94 percent. This is a 53.85 percent increase over losses of $(1.17) per share
Benzinga Newsdesk
PRO
Assembly Biosciences Q4 EPS $1.30 Beats $(0.65) Estimate, Sales $42.469M Beat $7.423M Estimate
Assembly Biosciences (NASDAQ:ASMB) reported quarterly earnings of $1.30 per share which beat the analyst consensus estimate of $(0.65) by 300 percent. This is a 182.8 percent increase over losses of $(1.57) per share
Benzinga Newsdesk
PRO
Assembly Biosciences Q3 EPS $(0.72) Beats $(0.78) Estimate, Sales $10.789M Beat $7.459M Estimate
Assembly Biosciences (NASDAQ:ASMB) reported quarterly losses of $(0.72) per share which beat the analyst consensus estimate of $(0.78) by 7.1 percent. This is a 52.32 percent increase over losses of $(1.51) per share
Benzinga Newsdesk
PRO
Assembly Biosciences' Cash, Cash Equivalents And Marketable Securities Were $75M Projected To Fund Operations Into Mid-2026
Benzinga Newsdesk
PRO
Assembly Biosciences Q2 2025 EPS $(1.33) Beats $(1.36) Estimate, Sales $9.626M Beat $6.262M Estimate
Benzinga Newsdesk
